# An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD

> **NCT06022744** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 12 (estimated)

## Conditions studied

- To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD

## Interventions

- **DRUG:** LX109

## Key facts

- **NCT ID:** NCT06022744
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06022744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06022744, "An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06022744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*